BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9851876)

  • 21. Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.
    Albrecht JH; Poon RY; Ahonen CL; Rieland BM; Deng C; Crary GS
    Oncogene; 1998 Apr; 16(16):2141-50. PubMed ID: 9572495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
    Joseph LF; Ezhevsky S; Scott DW
    Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
    Hobeika AC; Subramaniam PS; Johnson HM
    Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
    Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K
    Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines.
    Kawa S; Nikaido T; Aoki Y; Zhai Y; Kumagaya T; Furihata K; Fujii S; Kiyosawa K
    Int J Cancer; 1997 Sep; 72(5):906-11. PubMed ID: 9311612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein.
    Herrera RE; Mäkelä TP; Weinberg RA
    Mol Biol Cell; 1996 Sep; 7(9):1335-42. PubMed ID: 8885230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells.
    Arvanitakis L; Yaseen N; Sharma S
    J Immunol; 1995 Aug; 155(3):1047-56. PubMed ID: 7636179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD; Weinberg RA
    Mol Cell Biol; 1997 Jul; 17(7):4059-69. PubMed ID: 9199341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pRb-related protein p130 is a possible effector of transforming growth factor beta 1 induced cell cycle arrest in keratinocytes.
    Herzinger T; Wolf DA; Eick D; Kind P
    Oncogene; 1995 Jun; 10(11):2079-84. PubMed ID: 7784052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
    Fautsch MP; Eblen ST; Anders RA; Burnette RJ; Leof EB
    J Cell Biochem; 1995 Aug; 58(4):517-26. PubMed ID: 7593274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of TGF-beta 1 (transforming growth factor-beta 1) on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells.
    Mazars P; Barboule N; Baldin V; Vidal S; Ducommun B; Valette A
    FEBS Lett; 1995 Apr; 362(3):295-300. PubMed ID: 7729516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
    Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
    Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
    Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
    Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.
    Cayrol C; Flemington EK
    EMBO J; 1996 Jun; 15(11):2748-59. PubMed ID: 8654372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line.
    Kuniyasu H; Yasui W; Kitahara K; Naka K; Yokozaki H; Akama Y; Hamamoto T; Tahara H; Tahara E
    Cell Growth Differ; 1997 Jan; 8(1):47-52. PubMed ID: 8993833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1.
    Shankland SJ; Pippin J; Flanagan M; Coats SR; Nangaku M; Gordon KL; Roberts JM; Couser WG; Johnson RJ
    Kidney Int; 1997 Apr; 51(4):1088-99. PubMed ID: 9083274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dependence of cyclin E-CDK2 kinase activity on cell anchorage.
    Fang F; Orend G; Watanabe N; Hunter T; Ruoslahti E
    Science; 1996 Jan; 271(5248):499-502. PubMed ID: 8560263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type V collagen is an epithelial cell cycle inhibitor that is induced by and mimics the effects of transforming growth factor beta1.
    Parekh TV; Wang XW; Makri-Werzen DM; Greenspan DS; Newman MJ
    Cell Growth Differ; 1998 May; 9(5):423-33. PubMed ID: 9607563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.